BioSpace News Archive

BioCapital

UM School of Medicine Researchers Receive Federal Funding to Rapidly Test New Treatments for COVID-19

Long-time Coronavirus Researcher Joins Collaboration to Rapidly Repurpose FDA-approved Drugs for COVID-19

June 18, 2020
·
5 min read
BioMidwest

AbbVie and Alpine Immune Ink $865 Million Deal to License Drug for Lupus and Other Inflammatory Diseases

Under the terms of the deal, AbbVie is paying Alpine an upfront payment of $60 million for rights to ALPN-101, a first-in-class dual CD28/ICOS costimulation antagonist.

June 18, 2020
·
3 min read
·
Mark Terry
Business

BIO 2020: Disruptive Thinking About Addiction Management

The session discussed three “out-of-the-box” innovations that apply to multiple types of addictions.

June 18, 2020
·
4 min read
·
Gail Dutton
Business

BioSpace Movers & Shakers, June 19

Biopharma and life sciences companies bolster their executive leadership teams and boards with these Movers & Shakers.

June 18, 2020
·
7 min read
·
Alex Keown
Career Advice

Tools and Tricks for Rising Above Applicant Tracking Systems

Of the resumes submitted to employers that use Applicant Tracking Systems (ATS), 75% are never seen by human eyes.

June 18, 2020
·
4 min read
·
Katharine Hansen, PhD
BioForest

Research Roundup: Predicting Susceptibility to COVID-19 and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

June 18, 2020
·
4 min read
·
Mark Terry
Drug Development

New Study Shows ‘Nanosponges’ May Help Neutralize the Coronavirus

A new study published on Wednesday in the journal Nano Letters showed that cellular nanosponges may be able to inhibit SARS-CoV-2 infectivity within the body, ultimately neutralizing the virus.

June 18, 2020
·
3 min read
·
Krystle Vermes
Drug Development

Biopharma Update on the Novel Coronavirus: June 19

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 19, 2020.

June 18, 2020
·
4 min read
·
BioSpace Editorial Staff
Policy

Pharma Industry Wins Appeal Over Price Disclosures in Commercials

The U.S. Court of Appeals upheld a ruling that the Trump administration does not have the legal authority to mandate that drug companies disclose the list price of medications in television advertisements.

June 18, 2020
·
2 min read
·
Alex Keown
Pharm Country

Can CAR-T Cells Be Used to Treat Diseases like Diabetes and Fibrosis?

New research out of the Memorial Sloan Kettering Cancer Center suggests the genetically engineered immune cells can be used to treat diseases of senescence, which could include fibrotic liver disease, atherosclerosis, and diabetes.

June 18, 2020
·
3 min read
·
Mark Terry